Blockchain Technology

From PhUSE Wiki
Jump to: navigation, search


Project Overview

Project Scope

Introduce BlockChain and describe how it works
Pre-requisites to adopt BlockChain
Understanding the qualities of BlockChain relevant to the Pharma setting and the example of use cases and applications
Provide high level analysis of Pros/Cons of BlockChain in Pharma and Healthcare

Affected Stakeholders include those involved with:

Pharmaceutical and Biotechnology, CRO's, Regulators, Patients, Patient Advocate Groups, Non-Profit Organisations (such as CDISC, HL7, Pistoia),IT providers/vendors, Other healthcare providers.

Project Leads

Name Role Organization E-mail
Disa Lee Choun Co-Lead UCB Disa.LeeChoun@ucb.com
Christopher Hart Co-Lead Manchester Informatics Christopher.hart@manchesterinformatics.com
Adama Ibrahim Co-Lead Biogen Adama.ibrahim@biogen.com
Aji Barot Co-Lead Health Unlocked aji.barot@healthunlocked.com

Project Members

Name Organisation
Abdullah Albeyatti Medicalchain
Anca Petre 23Consulting
Anders Bergk Merck
Anders Vidstrup NNIT
Bob Clay Highbury Regulatory Science Limited
Carol Cheng Taiwan Research Based Biopharmaceutical Manufacturers Association
Cyran Marek bah
Ellen Vermaere UCB
Eric Du Gilead
Fernand Maes Johnson&Johnson
Hakim Mohamed Biosolutions Clinical Research Centre
Hariprasad Radhakrishnan AstraZeneca
Heather Flannery ObesityPMM
Imran Shakur Biogen
Jeremy Walsh FDA
Jim Nasr CDC
Karin Beckstorm ERT
Kanishk Singh ZS
Kenneth Getz Director of Sponsored Research Programs & Research Associate Professor
Kenneth NG Hashed Health
Loretis Alisauskas IBM
Lucy Hoch Astrazeneca
Lucy Ojomoko Longenesis
Maria Palombini IEEE
Marc Casals UCB
Mark Graves BAH
Dr Mayur R Joshi Biogen
Michael Wise Syneoshealth
Matt Rose SAAVHA
Nicole Tay Mercantis
Pascal Bouquet Novartis
Philip Clothiaux Hashed Health
Rajan Patel GE Healthcare
Ravi Malireddy Artificial Intelligence
Rhea Mehta Bowhead Health
Richard Shute Curlew Research
Ryan Banze Lilly
Scott Askin Novartis
Selina Lee IBM
Siva Thiagarajan Cognizant
Skip Francis FDA
Stanley Wei Novartis
Sven Greiner HMS Analytical Software
Todd Culverwell UCB
Troy Bannister ParticleHealth
Vahan Simonyan FDA
Vasil Todorov GSK
William Ivy Johnson&Johnson
Xavier Briand Novartis
Yusef Ghadiali Biogen
Zakaria Arrassi UCB

Project Updates

Provide project updates in this section.
Date: Description of Update

Objectives and Timelines

List proposed project deliverables and timelines.

Objective Timeline
Kick off Meeting Sept 2017
Sub Group Formation Sept 2017
Sub Section Headings (PhUSE Template) Oct 2017
100 Words for PhUSE Presentation Nov 2017
Decide on Use Cases Nov 2017
Researching and Send Draft for Team Review Dec 2017
Review Cycle 1-2 weeks turnaround Dec 2017
Sub Group incorporate comments from review Jan 2018
Sub Group Share Final Draft for merging of all sections Jan 2018
Review Cycle 2-Final Ream Review (2 weeks turnaround) 16th March 2018
WG Co-leads and SWG leads Group finalise the document 30 March 2018
Final Review-PhUSE/Independent Reviewer 30 Mar 2018
WG Co-leads and SWG leads Group to update and finalise document for publishing April 2018
WG members to work/finalise presentation slides for conference April 2018

Project Activities

This section can document project activities or serve as a jumping off point to other pages in the project.

Meeting Minutes

Webinar Presentations